KS

Kadiyam Sivaprakash

Active Director Director DIN 08086226
DIN 08086226 First appointment Mar 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Kadiyam Sivaprakash

Data last updated:

Kadiyam Sivaprakash is a Director at Dulse Pharmaceuticals Private Limited (since 2018). The company operates in Pharma.

DIN 08086226
Primary Designation Director
Industry Pharma
First Appointment 14 Mar 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Mar 20182018Active

Board colleagues of Kadiyam Sivaprakash

NameDINCompanyDesignation
Jayasri Delli08086227Dulse Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dulse Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kadiyam Sivaprakash

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kadiyam Sivaprakash

Kadiyam Sivaprakash currently holds 1 directorship: Dulse Pharmaceuticals Private Limited (Director, since 14 Mar 2018).

Kadiyam Sivaprakash was first appointed on 14 Mar 2018 as Director at Dulse Pharmaceuticals Private Limited.

The current boards of Kadiyam Sivaprakash's companies include Jayasri Delli (Dulse Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available